CMS issues final regulations for Medicare Advantage and prescription drug benefit (Part D) programs

CMS issues final regulations for Medicare Advantage and prescription drug benefit (Part D) programs

Drugstorenews.com: May 20, 2014 | By Michael Johnsen

BALTIMORE — The Centers for Medicare and Medicaid Services on Monday issued final regulations for the Medicare Advantage and prescription drug benefit (Part D) programs. The final rule is projected to save an estimated $1.6 billion over the next 10 years, the agency reported.

“The policies finalized in this regulation will strengthen Medicare by providing better protections and improving health care quality for beneficiaries participating in Medicare health and drug plans,” stated Marilyn Tavenner, CMS administrator.  “The final rule will give CMS new and enhanced tools in combating fraud and abuse in the Medicare Part D program so that we can continue to protect beneficiaries and taxpayers.”

Read full article here: http://drugstorenews.com/article/cms-issues-final-regulations-medicare-advantage-and-prescription-drug-benefit-part-d-program

 

NACDS supports Senate letter to HHS urging more time to implement Medicaid reimbursement

NACDS supports Senate letter to HHS urging more time to implement Medicaid reimbursement

Drugstorenews.com – May 21, 2014 | By Antoinette Alexander

ARLINGTON, Va. — Citing the need for a one-year transition period for states to implement the July average manufacturer price-based federal upper limits, or FULs, nine Senators are urging Department of Health and Human Services Secretary Kathleen Sebelius to consider the challenges that states will face when the final Medicaid AMP-based FULs are published. The National Association of Chain Drug Stores has expressed its support for sending the letter.

In July, CMS will publish the final Medicaid AMP-based FULs.  The agency has indicated that it expects the new FULs to be effective immediately.

Read full article here: http://www.drugstorenews.com/article/nacds-supports-senate-letter-hhs-urging-more-time-implement-medicaid-reimbursement?utm_source=MagnetMail&utm_medium=email&utm_term=support@inventoryRx.com&utm_content=DSN-NLE-DSNam-05-22-14

 

Teva whacking 11 plants for sure, another 16 being evaluated

Teva whacking 11 plants for sure, another 16 being evaluated

Drugmaker looking to cut $2B in costs by end of 2017
May 5, 2014 | By

The top dogs at Teva Pharmaceutical Industries have been saying for more than a year that to help cut $2 billion in costs, its manufacturing network needed to be trimmed and its API business cinched up. Now, new CEO Erez Vigodman has put some numbers to the calculation: 11 plants are slated for closure and another 16 are still under evaluation.

Vigodman, in his call with analysts last week, did not say which plants or how many jobs would be lost but did say Teva ($TEVA) has already started in on the reduction, according to a transcript of the call from SeekingAlpha. He also said that the cost-cutting should result in $1 billion in annual savings at the end of this year and another $1 billion cast aside by 2017, with $500 million falling to the bottom line by the end of that year.

“There is a lot of value we can unlock from getting our house in order by delivering on our cost reduction program, by accelerating operational network transformation and integration and by strengthening our global generic leadership, while improving profitability,” Vigodman said.
Read more: Teva whacking 11 plants for sure, another 16 being evaluated – FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/teva-whacking-11-plants-sure-another-16-being-evaluated/2014-05-05#ixzz31XLG0wxj

 

NCPA Launches Ads, Web Page Advocating for Pharmacy Choice in Medicare Drug Plans

NCPA Launches Ads, Web Page Advocating for Pharmacy Choice in Medicare Drug Plans

By Kevin Schweers

Nearly 400 independent community pharmacists have come to Washington, D.C. to advocate for their patients and their communities as part of the National Community Pharmacists Association (NCPA) Conference on National Legislation and Government Affairs. While they will visit several hundred congressional offices, they may not reach 100 percent of Capitol Hill. So To complement their advocacy efforts, NCPA is running advertisements to echo the work of NCPA members.

 

Most of the ads focus on NCPA’s top priority—ensuring that every community pharmacy has the opportunity to participate as ‘preferred’ pharmacies in Medicare drug plans.

Pharmacy choice” was the first online ad. Alongside the image, NCPA noted:

Patients prefer independent community pharmacies, surveys show, so give seniors choice. Allow independent community pharmacies to offer “preferred” pharmacy pricing in Medicare Part D drug plans. Right now sweetheart Big Box pharmacy deals are stifling competition. Some Medicare Part D drug plan middlemen have made Big Box pharmacies the “preferred” pharmacy, whether patients like it or not. Independent community pharmacies are often excluded and seek the opportunity to match the “preferred” pharmacy pricing and other contract terms and conditions. This pharmacy choice policy, also known as “any willing pharmacy,” has bipartisan support in Congress, is backed by leading consumer groups and is the best way to increase competition and lower costs in the Part D program.

This ad launched in conjunction with and links to an accompanying Web page—www.ncpanet.org/pharmacychoice—which is a reference point for NCPA’s push for its top priority. The page features key points focused at consumers, government and links to grassroots action alerts that concerned individuals can personalize and send.

That ad was followed by “30 miles.” It features a puzzled consumer holding a prescription and wondering, “Would you ‘prefer’ a pharmacy that’s 30 miles away?” It also links to www.ncpanet.org/pharmacychoice and noted

Independent community pharmacies are the sole pharmacies in many rural areas, but are denied the opportunity to be “preferred” pharmacies in many Medicare Part D drug plans. In about 1,800 rural communities, independent pharmacies are the only pharmacy provider. The next closest pharmacy is many miles away. Independent community pharmacies are excluded from “preferred” pharmacy deals between Big Box pharmacies and Medicare Part D drug plan middlemen. Independent community pharmacies seek only the opportunity to match “preferred” pharmacy pricing and other contract terms and conditions at no added cost to Medicare or seniors. This pharmacy choice policy, also known as “any willing pharmacy,” is supported by the National Rural Health Association and other leading consumer groups.

A third NCPA ad featured a map illustrating the important of independent community pharmacies by state and listed the three top priorities that community pharmacists are advocating:

  • Support pharmacy choice in Medicare Part D. Don’t force rural seniors to travel 20+ miles to a “preferred” pharmacy. Allow any willing pharmacy to offer a drug plan’s “preferred” co-pays, which are currently limited to Big Box pharmacies.
  • Ensure adequate payments for generic drugs; back H.R. 4437. Pharmacists promote generic drugs to save money. But some generic prices are increasing 1,000% overnight while drug plan middlemen wait months to update reimbursement.
  • Expand pharmacists’ role in patient care to provide more health services to those in medically underserved areas. Co-sponsor H.R. 4190.

Read Full Article Here: http://ncpanet.wordpress.com/2014/05/07/ncpa-launches-ads-web-page-advocating-for-pharmacy-choice-in-medicare-drug-plans/